Steve Cutler
Steve Cutler is the chief executive of Nasdaq-listed clinical trials company Icon, whose remuneration declined by 34 percent to €4.83 million amid a challenging year for the sector, where drugmakers significantly reduced their research and development budgets.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
Steve Cutler, the chief executive of Nasdaq-listed clinical trials company Icon, saw his remuneration decline by 34 per cent.
4